ARCC vs PSEC: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: PSEC is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ARCC and PSEC share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ARCC and PSEC exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Ares Capital Corporation is a business development company (BDC), a listed vehicle that lends directly to middle-market US businesses, companies typically too small for public bond markets but too large for a local bank. It is the largest BDC by market value and is externally managed by an affiliate of Ares Management, one of the world's biggest alternative-credit managers, which gives it a deep origination platform and sponsor relationships. As of March 31, 2026 its portfolio investments totaled roughly $29.5 billion and net asset value was about $19.59 per share. New commitments in early 2026 skewed heavily to first-lien senior secured loans (around 56%), with the vast majority of the portfolio in floating-rate debt, so income tends to rise and fall with short-term interest rates.

Full ARCC guide

Prospect Capital Corporation is one of the larger publicly traded business development companies. A BDC is a type of company that lends money to and invests in privately held middle-market businesses, then distributes most of its taxable income to shareholders, which is why BDCs are popular with income investors. Prospect's portfolio spans first-lien and other senior secured loans, subordinated debt, and equity positions across a range of industries, along with exposure to real estate and structured credit. Its results are driven by net investment income, the interest and fees it earns minus its own borrowing and operating costs, and by changes in the fair value of its investments, which flow through to net asset value, or NAV, per share.

Full PSEC guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ARCC drivers: Scale and the Ares platform; Floating-rate income and interest rates.
• PSEC drivers: High monthly income stream; Shift toward first-lien, senior secured loans.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The central risk is credit quality: ARCC lends to leveraged private companies, so an economic slowdown can raise defaults and non-accruals, erode net asset value, and pressure the dividend. For PSEC, the central risk is credit risk: Prospect lends to private middle-market companies, and if borrowers struggle or default, the fair value of its investments and its NAV per share can fall, as the 2026 NAV decline showed.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ARCC if you believe its drivers more; PSEC if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ARCC and PSEC guides.

ARCC. Figures are approximate and tied to the asOf date; verify live numbers before acting. Unlike an operating company, a BDC is best judged on net asset value per share, whether the dividend is covered by net investment income, and the level of non-accruals, rather than on a traditional earnings multiple. A yield in the double digits reflects both the income design of the structure and the credit risk of lending to leveraged private companies, so a high headline yield is not automatically a bargain.

PSEC. Figures are approximate and tied to the asOf date; verify live numbers before acting. For a BDC, the most important gauges are net investment income and its coverage of the dividend, NAV per share and its trend, and whether the stock trades at a premium or discount to NAV, rather than a simple P/E. A high yield is not a measure of safety; the 2026 dividend cut and NAV decline show why coverage and credit quality matter more than the headline rate.

Headline figures (approximate, Jul 2026): ARCC shows portfolio investments ~$29.5 billion at fair value (as of Mar 31, 2026); verify live, net asset value per share ~$19.59 (as of Mar 31, 2026); BDCs are valued largely on price-to-NAV, quarterly dividend $0.48 per share declared for Q1 2026 (~$1.92 paid across full-year 2025), dividend yield Roughly high single digits to low double digits on market price; verify live as it moves with the share price; PSEC shows business type Business development company (BDC) lending to middle-market private firms, monthly dividend cut to $0.035 per share in 2026; said to be covered by net investment income, net asset value (nav) declined in 2026, contributing to a share-price drop, portfolio quality first-lien loans increased to about 72% of the portfolio.

ARCC and PSEC are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ARCC and PSEC exposure against your real portfolio. It is not an investment adviser.